Histopathology of Appendiceal Specimens From Patients With Appendicitis and Concomitant COVID-19
Background: COVID-19 is a disease caused by SARS-CoV-2, which uses angiotensin-converting enzyme 2 (ACE2) receptors to infect cells.Research suggests that gastrointestinal (GI) manifestations of COVID-19 indicate the presence of ACE2 receptors throughout the GI system, including the appendix, and has identified SARS-CoV-2 nucleic acid in appendiceal specimens.Our study aimed to elucidate the relationship between appendicitis and COVID-19 through a histopathological analysis of appendixes from patients who underwent appendectomy with coexisting positive polymerase chain reaction (C+) results.We hypothesized that a strong presence of SARS-CoV-2 nucleic acid would be present in appendiceal samples of C+ patients.Methods: We analyzed 34 appendiceal specimens from patients undergoing appendectomies from March 2020 to April 2022.Twenty-five specimens were from C+ patients, and nine were from C-patients; 5-μm sections of formalin-fixed paraffin-embedded tissue were subjected to C4d immunohistochemistry staining.SARS-CoV-2 nucleic acid was measured using RNAscope with a probe (V-nCoV2019-S; Advanced Cell Diagnostics, Newark, CA) against COVID-19, also on formalin-fixed paraffin-embedded tissue.Results: Of the 25 C+ appendiceal specimens, three (two focally, one patchy) contained SARS-CoV-2 nucleic acid (3 C+ vs. 0 C-; p = 0.553).C4d staining was variable and had no difference in intensity (p = 0.553) or quantity (p = 0.188) between COVID-19 status.There was no difference in appendiceal wall thickness between C+ and C-patients (2.28 mm C+ vs. 2.11 mm C-; p = 0.656).Conclusion: We found no differences in the presence of SARS-CoV-2 nucleic acid, C4d staining, or wall thickness between C+ and C-specimens.These findings indicate minimal histopathological differences between appendixes from C+ and C-patients, suggesting that SARS-CoV-2 was not heavily involved in the pathogenesis of appendicitis.
Authors
- Iris Filippone (ORCID: https://orcid.org/0009-0001-8222-8089)
- Nathaniel S. Harshaw
- Zahra Alipour (ORCID: https://orcid.org/0000-0001-5049-9784)
- Lindsey L. Perea (ORCID: https://orcid.org/0000-0002-1930-1175)
- Zhaohai Yang
- Katherine Moore
- Julie Reichert
- Samantha LaRosa
Institutions
- Hospital of the University of Pennsylvania (US)
- Lancaster General Hospital (US)
- University of Pennsylvania Health System (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Cureus
- Published
- 2026-11-13
- DOI
- https://doi.org/10.7759/cureus.119597
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Pennsylvania
- Perelman School of Medicine, University of Pennsylvania